Cipla reported INR10.82B in Pre-Tax Profit for its fiscal quarter ending in June of 2026.





Pre Tax Profit Change Date
Arca Biopharma USD -31.82M 2.24M Mar/2026
aTyr Pharma USD -153K 25.59M Mar/2026
Bio Path USD -976K 3.62M Sep/2025
Brainstorm Cell Therapeutics USD -2.11M 797K Sep/2025
Capricor Therapeutics USD -30.17M 5.6M Dec/2025
Cara Therapeutics USD -6.8M 1.9M Mar/2026
Cipla INR 10.82B 3.33B Jun/2026
Dr.Reddys Laboratories INR 5.54B 955M Jun/2026
Immunic USD -19.3M 6.28M Dec/2025
Minerva Neurosciences USD 22.51M 30.74M Sep/2024
Nektar Therapeutics USD -43.09M 8.39M Mar/2026
Sangamo BioSciences USD -36.05M 12.94M Jun/2024
Sun Pharmaceuticals INR 35.51B 6.76B Mar/2026
TherapeuticsMD USD -1.05M 241K Jun/2024
UPL INR -1000M 19.92B Jun/2026